Viewing Study NCT00281866


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2025-12-25 @ 2:12 PM
Study NCT ID: NCT00281866
Status: COMPLETED
Last Update Posted: 2016-10-12
First Post: 2006-01-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module